Dasatinib
Management of dasatinib-induced pleural effusion at PMID 20375898
Back
The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
I - Interstitial/parenchymal lung disease
XLI - Pulmonary edema - Acute lung injury - ARDS
XLV - Pleural and/or pericardial involvement
XLV.a
Pleural effusion (uni- or bilateral) (can accompany DI-LDs)
XLV.c
Pleural thickening - Fibrothorax
XLV.d
Pleural/pericardial effusion, ANA positive (DI lupus)
XLV.h
Chylothorax
XLV.i
Pleuritis (can cause chest pain)
XLV.m
Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)